| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.0035 | 1 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.0022 | 1 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0034 | 1 |
| mRNA | BMS-708163 | GDSC1000 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |